Join to View Full Profile
Division of Medical Oncology200 1st St SWRochester, MN 55905
Phone+1 507-255-5123
Dr. Orme is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2016 - 2019
University of Texas Southwestern Medical SchoolClass of 2016
Certifications & Licensure
MN State Medical License 2017 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Young Investigator Award Prostate Cancer Foundation, 2022
Clinical Trials
- Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors Start of enrollment: 2021 Apr 01
Publications & Presentations
PubMed
- Olanzapine for managing side effects from antiangiogenic tyrosine-kinase inhibitors.Regina M Koch, Miguel Muniz, Candy S Peskey, Aminah Jatoi, Kathryn J Ruddy
Journal of Pain and Symptom Management. 2025-05-03 - Current and future directions in theranostics for neuroendocrine prostate cancer.Gokce Belge Bilgin, Fabrice Lucien-Matteoni, Aadel A Chaudhuri, Jacob J Orme, Daniel S Childs
Cancer Treatment Reviews. 2025-05-01 - Evaluating therapeutic plasma exchange and protease inhibitors as mechanisms to reduce soluble mesothelin.Katherine E R Smith, Jennifer R Ayers-Ringler, Jacob J Orme, Fabrice Lucien, Yohan Kim
Scientific Reports. 2025-04-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
